Ruby Surgical And Allied Products Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 26-06-2024
- Paid Up Capital ₹ 1.05 M
as on 26-06-2024
- Company Age 52 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.25 Cr
as on 26-06-2024
- Satisfied Charges ₹ 1.81 Cr
as on 26-06-2024
- Revenue -0.79%
(FY 2022)
- Profit -28.83%
(FY 2022)
- Ebitda 155.51%
(FY 2022)
- Net Worth 6.77%
(FY 2022)
- Total Assets 3.53%
(FY 2022)
About Ruby Surgical And Allied Products
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.05 M.
The company currently has active open charges totaling ₹2.25 Cr. The company has closed loans amounting to ₹1.81 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ketan Rane and Alka Rane serve as directors at the Company.
- CIN/LLPIN
U31112MH1972PTC015832
- Company No.
015832
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 1972
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Jalgaon, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ruby Surgical And Allied Products Private Limited offer?
Ruby Surgical And Allied Products Private Limited offers a wide range of products and services, including Surgical Cotton, Cotton Balls, Cotton Pad, Eye Pad, Absorbent Cotton, Bandages, Surgical Bandage, Bandages & Dressing Disposables, Cotton Rolls, Medical Gauze.
Who are the key members and board of directors at Ruby Surgical And Allied Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ketan Rane  | Director | 15-Mar-1992 | Current |
| Alka Rane | Director | 12-Dec-1992 | Current |
Financial Performance of Ruby Surgical And Allied Products.
Ruby Surgical And Allied Products Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.79% decrease. The company also saw a substantial fall in profitability, with a 28.83% decrease in profit. The company's net worth moved up by a moderate rise of 6.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ruby Surgical And Allied Products?
In 2021, Ruby Surgical And Allied Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Mar 2016 | ₹2.25 Cr | Open |
Union Bank Of India Creation Date: 30 Jun 2009 | ₹9.00 M | Satisfied |
Union Bank Of India Creation Date: 30 Mar 2002 | ₹8.00 M | Satisfied |
How Many Employees Work at Ruby Surgical And Allied Products?
Ruby Surgical And Allied Products has a workforce of 25 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ruby Surgical And Allied Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ruby Surgical And Allied Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
